Akoya Biosciences Inc (AKYA)
2.51
-0.62
(-19.81%)
USD |
NASDAQ |
Nov 15, 12:31
Akoya Biosciences Cash and Short Term Investments (Quarterly): 45.22M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 45.22M |
| March 31, 2024 | 61.58M |
| December 31, 2023 | 83.12M |
| September 30, 2023 | 78.60M |
| June 30, 2023 | 93.33M |
| March 31, 2023 | 60.25M |
| December 31, 2022 | 81.22M |
| September 30, 2022 | 81.70M |
| Date | Value |
|---|---|
| June 30, 2022 | 87.61M |
| March 31, 2022 | 93.94M |
| December 31, 2021 | 113.08M |
| September 30, 2021 | 120.15M |
| June 30, 2021 | 135.46M |
| March 31, 2021 | 11.69M |
| December 31, 2020 | 17.01M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
11.69M
Minimum
Mar 2021
135.46M
Maximum
Jun 2021
77.60M
Average
81.70M
Median
Sep 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Bruker Corp | 148.10M |
| Azenta Inc | 595.84M |
| Harvard Bioscience Inc | 4.569M |
| Bionano Genomics Inc | 18.94M |
| Singular Genomics Systems Inc | 133.20M |